Ensign Peak Advisors, Inc
Position in AVR — Anteris Technologies Global Corp.
CIK 1454984
SALT LAKE CITY, UT
Position in AVR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,543,470
+$11,960,004 QoQ
Shares Held
2,390,200
+14.5% QoQ
Ownership
2.45%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#10
of 135 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $747,867,301 across 35 Medical Devices names. AVR ranks #5 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
5,881,367 | $251,016,743 | |
| 2 | ABT |
Abbott Laboratories
|
2,381,366 | $216,085,150 | |
| 3 | SYK |
Stryker Corp
|
519,263 | $163,484,762 | |
| 4 | MDT |
Medtronic plc
|
573,001 | $44,825,868 | |
| 5 | AVR |
Anteris Technologies Global Corp.
This page
|
2,390,200 | $23,543,470 | |
| 6 | EW |
Edwards Lifesciences Corp
|
159,272 | $14,407,745 | |
| 7 | DXCM |
Dexcom Inc
|
140,932 | $9,491,770 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
88,745 | $5,680,567 |
All Filings in AVR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,543,470 | 2,390,200 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,583,466 | 2,087,111 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,988,769 | 1,400,555 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,337,102 | 1,408,245 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,461,890 | 1,441,132 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,244,712 | 1,440,855 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,800,605 | 1,039,535 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||